FdaApplication

ANDA 215011

Back to search

Identifiers

Properties

PropertyValue
applicant_nameJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD
application_typeANDA
approval_date2022-07-26

Products (1)

ProductActive ingredientStrengthDosage form
BORTEZOMIBBORTEZOMIB3.5MG/VIALINJECTABLE;INTRAVENOUS, SUBCUTANEOUS

1 product